Spiess PE - Search Results

1

Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy.

Spiess PE, Lee AK, Leibovici D, Wang X, Do KA, Pisters LL. Spiess PE, et al. Cancer. 2006 Jul 15;107(2):275-80. doi: 10.1002/cncr.21979. Cancer. 2006. PMID: 16770783 Free article.

2

Symptomatic local recurrence of prostate carcinoma after radiation therapy.

Leibovici D, Lee AK, Cheung RM, Spiess PE, Kuban DA, Rosser CJ, Shen Y, Yang Y, Chichakli R, Pisters LL. Leibovici D, et al. Among authors: spiess pe. Cancer. 2005 May 15;103(10):2060-6. doi: 10.1002/cncr.20990. Cancer. 2005. PMID: 15822114 Free article.

3

Inadequacies of the current American Joint Committee on cancer staging system for prostate cancer.

Taylor SH, Merriman KW, Spiess PE, Pisters L. Taylor SH, et al. Among authors: spiess pe. Cancer. 2006 Feb 1;106(3):559-65. doi: 10.1002/cncr.21605. Cancer. 2006. PMID: 16369982 Free article.

4

Immediate versus staged urethrectomy in patients at high risk of urethral recurrence: is there a benefit to either approach?

Spiess PE, Kassouf W, Brown G, Highshaw R, Wang X, Do KA, Kamat AM, Czerniak B, Dinney CP, Grossman HB. Spiess PE, et al. Urology. 2006 Mar;67(3):466-71. doi: 10.1016/j.urology.2005.09.043. Urology. 2006. PMID: 16527559

5

Surgery for locally advanced disease.

Spiess PE, Leibovici D, Pisters LL. Spiess PE, et al. Curr Urol Rep. 2006 May;7(3):209-16. doi: 10.1007/s11934-006-0023-z. Curr Urol Rep. 2006. PMID: 16630524 Review.

6

Viable malignant germ cell tumor in the postchemotherapy retroperitoneal lymph node dissection specimen: can it be predicted using clinical parameters?

Spiess PE, Brown GA, Pisters LL, Liu P, Tu SM, Evans JG, Kamat AM, Black P, Tannir NM. Spiess PE, et al. Cancer. 2006 Oct 1;107(7):1503-10. doi: 10.1002/cncr.22181. Cancer. 2006. PMID: 16944534 Free article.

7

Predictors of outcome in patients undergoing postchemotherapy retroperitoneal lymph node dissection for testicular cancer.

Spiess PE, Brown GA, Liu P, Tannir NM, Tu SM, Evans JG, Czerniak B, Kamat AM, Pisters LL. Spiess PE, et al. Cancer. 2006 Oct 1;107(7):1483-90. doi: 10.1002/cncr.22182. Cancer. 2006. PMID: 16944541 Free article.

8

Chylous ascites after post-chemotherapy retroperitoneal lymph node dissection: review of the M. D. Anderson experience.

Evans JG, Spiess PE, Kamat AM, Wood CG, Hernandez M, Pettaway CA, Dinney CP, Pisters LL. Evans JG, et al. Among authors: spiess pe. J Urol. 2006 Oct;176(4 Pt 1):1463-7. doi: 10.1016/j.juro.2006.06.016. J Urol. 2006. PMID: 16952661

9

Surgically managed lymph node-positive prostate cancer: does delaying hormonal therapy worsen the outcome?

Spiess PE, Lee AK, Busby JE, Jordan JJ, Hernandez M, Burt K, Troncoso P, Merriman KW, Pisters LL. Spiess PE, et al. BJU Int. 2007 Feb;99(2):321-5. doi: 10.1111/j.1464-410X.2006.06648.x. Epub 2006 Nov 28. BJU Int. 2007. PMID: 17155975

10

Recurrence pattern and proposed surveillance protocol following post-chemotherapy retroperitoneal lymph node dissection.

Spiess PE, Brown GA, Liu P, Tu SM, Tannir NM, Evans JG, Kamat AM, Kassouf W, Pisters LL. Spiess PE, et al. J Urol. 2007 Jan;177(1):131-8. doi: 10.1016/j.juro.2006.08.092. J Urol. 2007. PMID: 17162023

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

506 results

Search Page

Filters